Literature DB >> 10829879

Vaccines for tomorrow.

S K Sood1.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 10829879     DOI： 10.1007/bf02753585

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  28 in total

Review 1.  Varicella vaccine: still at the crossroads.

Authors:  A A Gershon
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

Review 2.  Vaccine-preventable disease and immunization in the developing world.

Authors:  K J Bart; K F Lin
Journal:  Pediatr Clin North Am       Date:  1990-06       Impact factor: 3.278

3.  Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.

Authors:  H Peltola; H Käyhty; M Virtanen; P H Mäkelä
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

4.  Varicella: clinical manifestations, epidemiology and health impact in children.

Authors:  S R Preblud; W A Orenstein; K J Bart
Journal:  Pediatr Infect Dis       Date:  1984 Nov-Dec

Review 5.  Vaccine prevention of group B streptococcal disease.

Authors:  C J Baker
Journal:  Pediatr Ann       Date:  1993-12       Impact factor: 1.132

Review 6.  Vaccines: moving into the molecular era.

Authors:  J R Gilsdorf
Journal:  J Pediatr       Date:  1994-09       Impact factor: 4.406

7.  A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Authors:  P A Twumasi; S Kumah; A Leach; T J O'Dempsey; S J Ceesay; J Todd; C V Broome; G M Carlone; L B Pais; P K Holder
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

8.  Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.

Authors:  C H Simanjuntak; P O'Hanley; N H Punjabi; F Noriega; G Pazzaglia; P Dykstra; B Kay; A Budiarso; A R Rifai
Journal:  J Infect Dis       Date:  1993-11       Impact factor: 5.226

Review 9.  Prospects for overcoming maturational and genetic barriers to the human antibody response to the capsular polysaccharide of Haemophilus influenzae type b.

Authors:  P Anderson; R A Insel
Journal:  Vaccine       Date:  1988-04       Impact factor: 3.641

10.  Necrotizing fasciitis as a complication of chickenpox.

Authors:  P A Falcone; V E Pricolo; L E Edstrom
Journal:  Clin Pediatr (Phila)       Date:  1988-07       Impact factor: 1.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.